Blue Clay Capital Management’s Surgalign Holdings, Inc. Common Stock SRGA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q3
$168K Sell
1,787
-1,033
-37% -$104K 0.19% 88
2016
Q2
$304K Sell
2,820
-1,093
-28% -$128K 0.35% 67
2016
Q1
$470K Hold
3,913
0.44% 55
2015
Q4
$466K Buy
3,913
+333
+9% +$43K 0.39% 65
2015
Q3
$610K Buy
3,580
+963
+37% +$185K 0.49% 50
2015
Q2
$507K Buy
+2,617
New +$486K 0.29% 64

Other funds holding SRGA

Blue Clay Capital Management's SRGA Position: Q3 2016 in Review

Blue Clay Capital Management reduced its Surgalign Holdings, Inc. Common Stock (SRGA) stake by 37% in Q3 2016, selling an estimated $104K and leaving 1,787 shares worth $168K. The position accounts for 0.19% of the portfolio, ranked #88.

Blue Clay Capital Management first reported a position in SRGA in Q2 2015 and has held it in 6 quarters since. The position peaked at $610K in Q3 2015. 110 funds tracked by Wall St. Rank hold SRGA as of Q3 2016.

  • Blue Clay Capital Management held 1,787 shares of Surgalign Holdings, Inc. Common Stock worth $168K as of Q3 2016.
  • Blue Clay Capital Management sold 1,033 Surgalign Holdings, Inc. Common Stock shares in Q3 2016, an estimated $104K.
  • Surgalign Holdings, Inc. Common Stock made up 0.19% of Blue Clay Capital Management's portfolio in Q3 2016, its #88 holding.
  • Blue Clay Capital Management first reported a position in Surgalign Holdings, Inc. Common Stock in Q2 2015 and has held it in 6 quarters since.
  • Blue Clay Capital Management's Surgalign Holdings, Inc. Common Stock position peaked at $610K in Q3 2015.
  • 110 funds tracked by Wall St. Rank held Surgalign Holdings, Inc. Common Stock as of Q3 2016.

Based on Blue Clay Capital Management's 13F filing for Q3 2016, filed 14 Nov 2016.